<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119214">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01739270</url>
  </required_header>
  <id_info>
    <org_study_id>0911</org_study_id>
    <nct_id>NCT01739270</nct_id>
  </id_info>
  <brief_title>Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia</brief_title>
  <official_title>Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia After Supraclavicular Brachial Plexus Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Dubrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Dubrava</source>
  <oversight_info>
    <authority>Croatia: Ministry of Science, Education and Sports</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adding dexamethasone to local anesthetic will significantly prolong duration of brachial
      plexus anesthesia and analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Operations of upper extremities are often performed in regional anesthesia blocks.
      Single-injection blocks are effective, but time limited. Adding 4mg of dexamethasone to 0.5%
      levobupivacaine will significantly prolong duration of brachial plexus anesthesia and
      analgesia for fracture operations of upper extremity. This effect will result in less opioid
      use postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>duration of analgesia</measure>
    <time_frame>24 hour postoperatively</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Duration of analgesia after supraclavicular block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative analgesic consumption</measure>
    <time_frame>24 hour</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Brachial Plexus Anesthesia</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>dexamethasone with levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25ml 0.5% levobupivacaine plus 4mg Dexamethasone are given for supraclavicular brachial plexus block for upper extremity surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25ml 0.5% levobupivacaine plus 1ml 0.9% saline are given for supraclavicular brachial plexus block for upper extremity surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>supraclavicular brachial plexus block</intervention_name>
    <arm_group_label>dexamethasone with levobupivacaine</arm_group_label>
    <arm_group_label>levobupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged 18 years or older

          -  ASA (American Society of Anesthesiologists) physical status I, II or III

        Exclusion Criteria:

          -  refusal of the patients to give informed consent

          -  preexisting coagulation disorders

          -  local infection at the site of the block

          -  neuropathy

          -  drug or alcohol abusers

          -  known allergy to the drug used in study

          -  operation time exceeding six hours
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ino Husedzinovic, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Hospital Dubrava, Head of Anesthesiology, Resuscitation and Intensive Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Hospital Dubrava</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <results_reference>
    <citation>Parrington SJ, O'Donnell D, Chan VW, Brown-Shreves D, Subramanyam R, Qu M, Brull R. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus blockade. Reg Anesth Pain Med. 2010 Sep-Oct;35(5):422-6.</citation>
  </results_reference>
  <results_reference>
    <citation>Vieira PA, Pulai I, Tsao GC, Manikantan P, Keller B, Connelly NR. Dexamethasone with bupivacaine increases duration of analgesia in ultrasound-guided interscalene brachial plexus blockade. Eur J Anaesthesiol. 2010 Mar;27(3):285-8. doi: 10.1097/EJA.0b013e3283350c38.</citation>
    <PMID>20009936</PMID>
  </results_reference>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 25, 2013</lastchanged_date>
  <firstreceived_date>November 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Dubrava</investigator_affiliation>
    <investigator_full_name>Jasminka Persec, MD, PhD</investigator_full_name>
    <investigator_title>Anesthesiology, Resuscitation and Intensive Care Medicine Specialist</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>surgery</keyword>
  <keyword>duration of analgesia</keyword>
  <keyword>dexamethasone added to levobupivacaine compared to levobupivacaine alone</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
